ETX.L Gross Margin

The Gross Margin of E-Therapeutics PLC (ETX.L) is 100.00%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ETX.L Gross Margin - Historical Value

Date	Value
2023-01-31	100.00%
2022-01-31	100.00%
2021-01-31	100.00%
2020-01-31	100.00%
2019-01-31	100.00%

ETX.L Gross Margin - Peers Comparison

Ticker	Name	Value
ORY.MC	Oryzon Genomics SA	-4700.00%
SANION.ST	Saniona AB	85.03%
ABC.L	Abcam PLC	71.12%
AEGIR.ST	Aegirbio AB	47.83%
ALSEN.PA	Sensorion SA	7775.20%
BCYC	Bicycle Therapeutics PLC	7775.20%
LIDDS.ST	Lidds AB	-1102.81%
RENE.L	ReNeuron Group PLC	100.00%
TRVX.OL	Targovax ASA	7775.20%
GNS.L	Genus PLC	36.68%
KURN.SW	Kuros Biosciences AG	109.30%
OXB.L	Oxford Biomedica PLC	41.17%
PCIB.OL	PCI Biotech Holding ASA	100.00%
PUR.WA	Pure Biologics SA	-2709.47%
MDG1.DE	Medigene AG	72.77%
MYOV	Myovant Sciences Ltd	77.68%
OXUR.BR	Oxurion NV	-1333.33%
SENZA.ST	SenzaGen AB	66.89%
TRX.L	Tissue Regenix Group PLC	47.60%
IMCR	Immunocore Holdings PLC	99.12%
ALHYG.PA	Hybrigenics SA	99.47%
ALLR.ST	Allarity Therapeutics A/S	-175.91%
ALQGC.PA	Quantum Genomics SA	-14205.07%
ATORX.ST	Alligator Bioscience AB	-312.94%
FARN.L	Faron Pharmaceuticals Oy	95.19%
SLN.L	Silence Therapeutics PLC	3133.78%
T5O.DE	bioXXmed AG	100.00%
ADOC.PA	Adocia SA	87.98%
CNTA	Centessa Pharmaceuticals PLC	7775.20%
GV.PA	Genomic Vision SA	-165.01%
MVIR B.ST	Medivir AB	-1470.45%
GNRO.PA	Geneuro SA	7775.20%
VSC.DE	4Sc AG	97.20%
ADAP	Adaptimmune Therapeutics PLC	99.96%
BLR.WA	Blirt SA	77.13%
CMPS	Compass Pathways PLC	7775.20%
EGTX.ST	Egetis Therapeutics AB (publ)	74.84%
MDXH.BR	MDxHealth SA	51.74%